Danaher Co. (DHR) Stake Increased by Destination Wealth Management
Destination Wealth Management raised its position in shares of Danaher Co. (NYSE:DHR) by 113.3% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 240,120 shares of the conglomerate’s stock after acquiring an additional 127,553 shares during the period. Danaher comprises about 1.4% of Destination Wealth Management’s investment portfolio, making the stock its 27th largest holding. Destination Wealth Management’s holdings in Danaher were worth $22,288,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently bought and sold shares of DHR. GSA Capital Partners LLP grew its stake in shares of Danaher by 22.3% during the second quarter. GSA Capital Partners LLP now owns 21,912 shares of the conglomerate’s stock valued at $1,849,000 after purchasing an additional 3,991 shares during the last quarter. D.A. Davidson & CO. grew its stake in shares of Danaher by 17.4% during the second quarter. D.A. Davidson & CO. now owns 10,015 shares of the conglomerate’s stock valued at $845,000 after purchasing an additional 1,483 shares during the last quarter. Vanguard Group Inc. grew its stake in shares of Danaher by 1.3% during the second quarter. Vanguard Group Inc. now owns 41,488,407 shares of the conglomerate’s stock valued at $3,501,206,000 after purchasing an additional 520,776 shares during the last quarter. FMR LLC grew its stake in shares of Danaher by 0.9% during the second quarter. FMR LLC now owns 19,624,350 shares of the conglomerate’s stock valued at $1,656,100,000 after purchasing an additional 183,183 shares during the last quarter. Finally, ETRADE Capital Management LLC grew its stake in shares of Danaher by 5.1% during the second quarter. ETRADE Capital Management LLC now owns 19,075 shares of the conglomerate’s stock valued at $1,610,000 after purchasing an additional 917 shares during the last quarter. 77.05% of the stock is owned by institutional investors.
Several analysts have recently commented on the stock. Credit Suisse Group increased their price target on shares of Danaher from $99.00 to $105.00 and gave the company an “outperform” rating in a research note on Wednesday, January 31st. Stifel Nicolaus increased their price target on shares of Danaher from $110.00 to $115.00 and gave the company a “buy” rating in a research note on Wednesday, January 31st. Zacks Investment Research cut shares of Danaher from a “buy” rating to a “hold” rating in a research note on Tuesday, December 19th. Robert W. Baird reissued a “buy” rating on shares of Danaher in a research note on Friday, January 12th. Finally, Barclays assumed coverage on shares of Danaher in a research note on Thursday. They set an “overweight” rating and a $110.00 price target on the stock. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the stock. The company has a consensus rating of “Buy” and an average target price of $100.68.
Danaher Co. (NYSE DHR) opened at $97.54 on Monday. Danaher Co. has a 52 week low of $78.97 and a 52 week high of $104.82. The stock has a market cap of $67,946.36, a P/E ratio of 24.20, a price-to-earnings-growth ratio of 2.05 and a beta of 1.04. The company has a quick ratio of 1.05, a current ratio of 1.43 and a debt-to-equity ratio of 0.39.
Danaher (NYSE:DHR) last announced its quarterly earnings data on Tuesday, January 30th. The conglomerate reported $1.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.16 by $0.03. Danaher had a net margin of 13.60% and a return on equity of 11.36%. The firm had revenue of $5.09 billion for the quarter, compared to analysts’ expectations of $4.97 billion. During the same period last year, the firm earned $1.05 earnings per share. The business’s revenue for the quarter was up 10.9% on a year-over-year basis. equities research analysts predict that Danaher Co. will post 4.37 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, January 26th. Shareholders of record on Friday, December 29th were paid a $0.14 dividend. The ex-dividend date was Thursday, December 28th. This represents a $0.56 dividend on an annualized basis and a yield of 0.57%. Danaher’s payout ratio is presently 15.86%.
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.